Ftse Mib
34.243,49
-0,39%
DAX
18.481,29
-0,64%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,00%
Bitcoin
63.850,94
-1,54%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Adicet Bio Inc (ACET) Adicet Bio Inc (ACET) Notizie

ACET

Adicet Bio (ACET)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ACET
DataOraFonteTitoloSimboloCompagnia
18/05/202312:00Business WireAdicet Bio Presents Positive Preclinical Data on ADI-270 at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual MeetingNASDAQ:ACETAdicet Bio Inc
09/05/202322:30Business WireAdicet Bio to Present at the 2023 JMP Securities Life Sciences ConferenceNASDAQ:ACETAdicet Bio Inc
09/05/202322:19Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACETAdicet Bio Inc
09/05/202322:10Business WireAdicet Reports First Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:ACETAdicet Bio Inc
28/04/202323:13Business WireAdicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
18/04/202322:31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ACETAdicet Bio Inc
18/04/202322:29Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ACETAdicet Bio Inc
13/04/202313:00Business WireAdicet Bio to Participate in 2023 Canaccord Genuity Horizons in Oncology Virtual ConferenceNASDAQ:ACETAdicet Bio Inc
15/03/202321:14Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ACETAdicet Bio Inc
15/03/202321:09Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ACETAdicet Bio Inc
15/03/202321:05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACETAdicet Bio Inc
15/03/202321:01Business WireAdicet Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Company ProgressNASDAQ:ACETAdicet Bio Inc
13/03/202321:00Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ACETAdicet Bio Inc
09/03/202313:00Business WireAdicet Bio to Participate in 2023 Jefferies Biotech on the Bay SummitNASDAQ:ACETAdicet Bio Inc
14/02/202323:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACETAdicet Bio Inc
14/02/202318:52Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACETAdicet Bio Inc
01/02/202313:00Business WireAdicet Bio to Participate in a Fireside Chat at the 2023 Guggenheim Oncology ConferenceNASDAQ:ACETAdicet Bio Inc
12/12/202220:20TipRanksAdicet Bio Stock Craters 36% on Phase 1 Clinical DataNASDAQ:ACETAdicet Bio Inc
12/12/202206:25TipRanksAdicet Bio (ACET) Gets a Buy from JMP SecuritiesNASDAQ:ACETAdicet Bio Inc
11/12/202219:15TipRanksJonesTrading Sticks to Their Buy Rating for Adicet Bio (ACET)NASDAQ:ACETAdicet Bio Inc
10/12/202216:00Business WireAdicet Bio Reports Positive Data from Ongoing ADI-001 Phase 1 Trial in Patients with Relapsed or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphoma (NHL)NASDAQ:ACETAdicet Bio Inc
02/12/202213:00Business WireAdicet Bio to Host Investor Webcast to Discuss Updated Clinical Data from Ongoing ADI-001 Phase 1 Trial in Patients with Relapsed or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphoma (NHL)NASDAQ:ACETAdicet Bio Inc
30/11/202222:00Business WireAdicet Bio to Present at the Virtual JMP Securities Hematology and Oncology SummitNASDAQ:ACETAdicet Bio Inc
29/11/202213:00Business WireAdicet Bio Appoints Nancy Boman, M.D., Ph.D., as Senior Vice President and Chief Regulatory OfficerNASDAQ:ACETAdicet Bio Inc
14/11/202204:56TipRanksBTIG Remains a Buy on Adicet Bio (ACET)NASDAQ:ACETAdicet Bio Inc
10/11/202220:35TipRanksAdicet Bio (ACET) Receives a Buy from JonesTradingNASDAQ:ACETAdicet Bio Inc
08/11/202222:10Business WireAdicet Reports Third Quarter 2022 Financial Results and Provides Business UpdatesNASDAQ:ACETAdicet Bio Inc
07/11/202214:00Business WireAdicet Bio Showcases Preclinical Data for Four New Pipeline Programs at The Society for Immunotherapy of Cancer (SITC) 37th Annual MeetingNASDAQ:ACETAdicet Bio Inc
04/11/202206:36TipRanksBTIG Keeps Their Buy Rating on Adicet Bio (ACET)NASDAQ:ACETAdicet Bio Inc
03/11/202217:25TipRanksH.C. Wainwright Remains a Buy on Adicet Bio (ACET)NASDAQ:ACETAdicet Bio Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ACET

La tua Cronologia

LSE
0RO4
Jww Invest
USOTC
WKGBF
Sanderson Design (PK)
BIT
UC3S7S
Unicredit Bank
LSE
0IPT
Akastor Asa
LSE
0A6J
Southwestern Energy
NASDAQ
TWGP
LSE
ESG
Eservglobal
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network